Domestic Drugmakers Will Reap Little Benefits From Egypt's Pharmaceutical Market Growth
Pharma & Healthcare / Egypt / Mon 03 Feb, 2020
Key View
- Supported by strong underlying factors and roll-out of universal healthcare, Egypt’s pharmaceutical market will post robust growth in the coming years.
- Strong competition from foreign firms and currency fluctuations will present a challenging environment for Egyptian drugmakers.
- This is compounded by restrictive pricing policies and